New Zealand markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
278.34-8.02 (-2.80%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
7,769,825
482,325
108,589
127,575
61,598
Cost of revenue
1,164,733
59,333
17,361
13,690
9,318
Gross profit
6,605,092
422,992
91,228
113,885
52,280
Operating expenses
Research development
904,062
647,062
226,466
143,040
85,496
Selling general and administrative
172,124
101,424
43,410
27,090
29,492
Total operating expenses
768,811
512,411
272,746
167,738
113,557
Operating income or loss
5,836,281
-89,419
-181,518
-53,853
-61,277
Interest expense
2,303
2,003
1,718
1,721
676
Total other income/expenses net
-162,296
-52,896
2,341
5,966
-26,033
Income before tax
5,663,198
-145,802
-179,440
-47,662
-85,905
Income tax expense
1,591,000
-161,000
-268
600
45
Income from continuing operations
4,072,198
15,198
-179,172
-48,262
-85,950
Net income
4,072,198
15,198
-179,056
-48,019
-85,653
Net income available to common shareholders
4,072,198
15,198
-179,056
-48,019
-85,653
Basic EPS
-
0.06
-0.85
-0.21
-0.38
Diluted EPS
-
0.06
-0.85
-0.21
-0.38
Basic average shares
-
253,300
211,499
226,262
226,262
Diluted average shares
-
253,300
211,499
226,262
226,262
EBITDA
-
-105,055
-143,826
-23,957
-74,700